PQ 1062
1062. Deputy Michael Lowry asked the Minister for Health the approval and reimbursement status of the targeted immunotherapy zolbetuximab (Vyloy®) for the treatment of metastatic gastric adenocarcinoma (detail supplied). [6213/26]
Introduced
27 January 2026
Last action
—
Status
written
Sponsors
—
Subjects
Discovery layer
Source updated
27 January 2026
Summary
1062. Deputy Michael Lowry asked the Minister for Health the approval and reimbursement status of the targeted immunotherapy zolbetuximab (Vyloy®) for the treatment of metastatic gastric adenocarcinoma (detail supplied). [6213/26]
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
No timeline events have been ingested for this record yet.
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
1 official file
Health Service Executive
Health Service Executive
xml · EN · 27 January 2026
Sponsors
No sponsors or actors listed by the source.
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://www.oireachtas.ie/en/debates/question/2026-01-27/1062/
- Open data entity: https://data.oireachtas.ie/ie/oireachtas/question/2026-01-27/pq_1062